Showing all published months. Partner preview tables include up to 5 countries.
CSV orders from USD 9.90 ยท One-time purchase. Review coverage and your total before payment.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Denmark | $1.2B | 56.2% |
| France | $628.1M | 30.0% |
| Brazil | $171.2M | 8.2% |
| Pakistan | $53.8M | 2.6% |
| Australia | $33.2M | 1.6% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| El Salvador | $192K | 100.0% |
| Year | Export value |
|---|---|
| 2021 | $1B |
| 2022 | $766.6M |
| 2023 | $143.2M |
| 2024 | $48M |
| 2025 | $94.1M |
| 2026 | $39.9M |
China customs reports HS 300431 at the 8-digit level. 2 subheadings are published under it, and export values for each are available on request.
Recombinant human insulin formulations prepared in measured doses or retail packaging provide genetically engineered diabetes treatments for direct patient administration.
Retail-packaged or measured-dose diabetes treatments derived from non-recombinant insulin sources, such as animal-derived extracts, are classified under this heading.
Public data shows up to 5 partner countries. Buy monthly partner trade values in CSV; choose HS8 for native quantity and unit fields where published.
CSV orders from USD 9.90 ยท One-time purchase. Confirm available coverage and your total in the order preview before paying.
Download after payment. Large packages may need preparation; delivery timing is confirmed before checkout.
Need help choosing products or regular updates? Ask us for a quote by email.
Sample files illustrate the delivery format. Preview your selected scope in the order builder.
HS 300431 is also written 3004.31. Values are in USD; the public series does not report tonnes or kg. Product scope: Insulin-based pharmaceutical products packaged for retail sale, typically consisting of consumer-ready diabetes treatments like vials, cartridges, or pre-filled injection pens for direct patient use. The public page shows monthly export partner previews from official GACC customs statistics. Preview and buy a monthly CSV for your selected products, countries and years.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments containing insulin (HS 300431) Export Data." https://chinadata.live/china-trade/hs/300431/
China exported $63.3M of medicaments containing insulin in the twelve months to August 2026, averaging $5.3M per month, based on official China customs statistics (HS 300431).
Insulin-based pharmaceutical products packaged for retail sale, typically consisting of consumer-ready diabetes treatments like vials, cartridges, or pre-filled injection pens for direct patient use.
Denmark, France and Brazil together account for 94% of the published total, out of 8 trading partners on record.
Annual exports declined by 91% between 2021 and 2025, from $1.0B to $94.1M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available as a one-time CSV purchase. Choose your products and coverage, then preview the file and price before payment.